PubRank

Antonina Azzolina

Author PubWeight™ 15.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget 2012 1.55
2 Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. Ann N Y Acad Sci 2004 1.09
3 Molecular mechanisms of sorafenib action in liver cancer cells. Cell Cycle 2012 1.01
4 Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle 2010 0.95
5 Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway. Cancer Biol Ther 2007 0.92
6 Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies. Drug Deliv 2007 0.89
7 The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism. Cancer Lett 2012 0.89
8 Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. Ann N Y Acad Sci 2009 0.88
9 Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism. Mol Pharmacol 2009 0.86
10 Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells. Exp Mol Med 2007 0.84
11 Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. Ann N Y Acad Sci 2009 0.83
12 Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery. J Drug Target 2007 0.83
13 COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells. OMICS 2011 0.82
14 The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells. Int J Mol Med 2006 0.80
15 Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. PLoS One 2013 0.79
16 Synthesis and characterization of polyaminoacidic polycations for gene delivery. Biomaterials 2005 0.76
17 Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells. J Nanobiotechnology 2014 0.75